Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune
 pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half
 of participants will receive corticosteroids alone, while the other half will receive
 corticosteroids with biliary stent at the beginning.
Inclusion Criteria:

 -  adults greater than 18 years-old;

 -  autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis;

 -  obstructive jaundice

 Exclusion Criteria:

 -  malignancies; active infections;

 -  pregnancy or breast feeding;

 -  standard contraindications to ERCP;

 -  unwillingness or inability to consent for the study